Towards Healthcare
Testicular Implants (Prosthesis) Market Size Soars USD 7.55 Billion by 2034

Testicular Implants (Prosthesis) Market Developments and Updates

Market insights predict the global testicular implants (prosthesis) industry will increase from USD 3.8 billion in 2024 to USD 7.55 billion by 2034, achieving a CAGR of 7.14%. In the world, increasing cases of testicular cancer along with rising concerns like cryptorchidism (undescended testicles) or monorchism (having only one testicle), resulting in the need for a prosthesis. North America led the market with a major share of the market, due to growing awareness, along with acceptance among patients, leading to the greater adoption of testicular implants. 

Content

  • Insight Code: 5793
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The testicular implants (prosthesis) market is projected to reach USD 7.55 billion by 2034, growing at a CAGR of 7.14% from 2024 to 2034.

North America is currently leading the testicular implants (prosthesis) market due to rising incidences of testicular cancer and growing awareness, along with acceptance among patients.

The testicular implants (prosthesis) market includes 4 segments, such as by product type, by material, by end-user, and by region etc.

Some key players include Coloplast Corporation, Allergan, Inc., Mentor Worldwide LLC, Promedon Group, and Silimed.

Key trends include rising demand for biocompatible and durable implants, growth in awareness related to mens health, and innovation in customized implants.

Torosa is the best testicular implant, approved by the FDA to create and preserve a natural appearance and feel of the testicles in the scrotum.

The risks of testicular implants are infection, hematoma, and dissatisfaction with surgery.

Testicular implants are usually made of a soft plastic (silicone) shell and filled with saline (salt water).

NIH.GOV, CDC.GOV, US FDA.GOV, CLINICALTRIALS.GOV, GOV.UK
Any Questions